Unless an investment in Elite was based upon all I've been told how Sequest has a Hammerlock on the IR ADF opioid space
As the first to market back peddling begins, let's also point out theres no assurance Sequest will be the 4th, 5th or 80th drug to market, if ever.. A miracle approval for Sequest is well over a year away and that's being aggressively optimistic
I don't need investopedia to tell me this is a serious problem for Elite.
Positive comments from Inspirions AdCom will be a major, material blow to Elite
Market Data 
Markets 
AI
